Surveillance

In this report, health disparities are measured by examining differences in HIV/AIDS, viral hepatitis, STDs, and tuberculosis surveillance data with respect to such sociodemographic factors as race/ethnicity, sex, and age. In addition, where possible, disparities are measured by examining differences by sexual orientation and geographic location. This report includes a retrospective review of CDC surveillance data for HIV/AIDS, viral hepatitis, STDs, and tuberculosis over the period 2000-2004.

A document on technical instructions for TB screening and treatment for panel physicians on persons overseas applying for U.S immigration status and non-immigrants who are required to have an overseas medical examination.

This fact sheet provides the latest information on the work USAID is doing to fight TB in Haiti.

The white paper, or policy document, outlines the strategic vision of NCHHSTP for reducing health disparities and promoting health equity among populations affected by these diseases. NCHHSTP is committed to promoting awareness, stakeholder and community engagement, and action on factors that can affect the nation and the world's health; to addressing these factors in the policy, practice, and research activities of NCHHSTP; and to building partnerships on every level.

This guide specifically addresses issues such as stigma and work discrimination, and also provides practical recommendations on how to establish an effective monitoring system.

This handbook provides detailed examples of the analysis of TB surveillance data, in particular TB notification data, data from surveillance of anti-TB drug resistance, and mortality data compiled in national vital registration systems.

This report presents a regional framework for addressing TB/HIV co-infection in the Western Pacific that is adapted to the epidemiological profile and health service system of the region and identifies areas in which both programs can complement each other to address TB/HIV.

This guideline sets forth the framework to guide European countries in developing their national plan for reducing TB/HIV morbidity and mortality. The framework sets out the rationale for effective collaboration between HIV/AIDS and tuberculosis national programs.

These guidelines have been developed to assist national TB control programs (NTPs) in adopting specific anti-TB drug resistance surveillance systems to measure susceptibility to first-line TB drugs.

This report, updated annually, details the global epidemiology of TB based on the data supplied by the national TB programs from WHO member states.